10/16/2012 - 9:26am

CVS Caremark has announced that it has reached a civil settlement with the United States Department of Justice regarding its investigation into certain business practices of a subsidiary of Longs Drug Stores, which began prior to the acquisition of Longs by CVS Caremark in October 2008.

10/15/2012 - 12:11pm

CVS/pharmacy is gearing up for Halloween with its second annual Family Halloween Party, a festive customer appreciation event hosted at all 7,400 stores nationwide.

10/15/2012 - 11:24am

With the start of Annual Enrollment Period on Monday for Medicare Part D prescription drug plans, CVS/pharmacy has announced that it is ready to help pharmacy patients who are enrolling in Medicare Part D for the first time or want to make a change to their current coverage plan.

10/11/2012 - 12:18pm

More than half of consumers say they do not plan to get a flu shot this season, according to a recent survey conducted by CVS/pharmacy.

10/10/2012 - 1:35pm

An executive from CVS Caremark will guide policy for a generic drug industry trade association.

10/09/2012 - 12:13pm

While CVS/pharmacy’s store clustering initiatives and store brands are fueling front-store profitability, there’s no doubt that its successful, long-standing ExtraCare loyalty program remains a key driver of front-store sales, and it arms the company with a powerful competitive advantage, especially as CVS looks to take the program to new heights. 


10/09/2012 - 12:13pm

CVS Caremark’s front-store business continues to experience solid performance despite a weak economy — success that can be credited to such factors as a skilled merchandising team, a focus on store brands and a clustering initiative that tailors stores’ merchandise mix based on how the stores are shopped in certain locations.


10/09/2012 - 12:13pm

CVS Caremark is also working to reinvent the role of its retail pharmacists and is gaining share by focusing on customer service, greater adherence, increased access and patient 
care improvements.

10/09/2012 - 12:13pm

Specialty may be the fastest-growing segment, but it may also be the most complicated, as this segment is comprised of very complex medications to treat such serious diseases as cancer, multiple sclerosis and hemophilia.